The US Department of Commerce is investigating the national security implications of importing medical devices and healthcare equipment, causing a drop in medtech stock prices. Companies like GE HealthCare and Becton Dickinson saw over a 4% decline on September 25. The investigation seeks feedback on the impact of imports and potential export restrictions.

The probe by the DOC focuses on the effects of medical device imports on national security, requesting comments within a 21-day window. Areas of interest include foreign export restrictions, reducing import reliance, and the impact of subsidies on competitiveness. AdvaMed expressed cautious optimism, hoping for strengthened US medtech manufacturing and lower tariffs.

Many medtech companies are revising tariff impact assumptions for the year, with some like Zimmer Biomet and Philips lowering expected impacts by over $100 million. The ongoing import probe by the Trump administration has left investors wary, with implications for the industry’s future. The investigation seeks to bolster American medtech manufacturing and reduce costs for hospitals and patients.

Read more at Yahoo Finance: US medtech stocks buffeted by Trump administration’s import probe